2005
DOI: 10.1016/j.biomaterials.2004.06.010
|View full text |Cite
|
Sign up to set email alerts
|

The decrease of particle-induced osteolysis after a single dose of bisphosphonate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
34
0
5

Year Published

2005
2005
2016
2016

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 54 publications
(40 citation statements)
references
References 17 publications
1
34
0
5
Order By: Relevance
“…Staining of the osteoclasts was partial and mild to moderate in both groups but the number of osteoclasts differed. There were 45.14 osteoclasts (range, in the Group II animals and 11.86 (range, [6][7][8][9][10][11][12][13][14][15][16][17][18] in the animals of Group IV, in the sham controls we counted 3.86 (range, 2-7) in Group I and 3.57 (range, 2-6) in Group III (Fig. 4).…”
Section: Histology and Immunohistochemistrymentioning
confidence: 92%
See 1 more Smart Citation
“…Staining of the osteoclasts was partial and mild to moderate in both groups but the number of osteoclasts differed. There were 45.14 osteoclasts (range, in the Group II animals and 11.86 (range, [6][7][8][9][10][11][12][13][14][15][16][17][18] in the animals of Group IV, in the sham controls we counted 3.86 (range, 2-7) in Group I and 3.57 (range, 2-6) in Group III (Fig. 4).…”
Section: Histology and Immunohistochemistrymentioning
confidence: 92%
“…More than 34% of the particles were smaller than 1 lm, with a mean particle size (given as equivalent circle diameter) of 1.74 ± 1.43 lm (range 0.05-11.6). A detailed morphological particle description has been recently published by our group [14].…”
Section: Particlesmentioning
confidence: 99%
“…Various in vitro and animal studies have shown encouraging results (Horowitz et al, 1996, Millett et al, 2002, Shanbhag et al, 1997, von Knoch et al, 2005. However currently, convincing results from clinical studies supporting the use of bisphosphonates are still lacking.…”
Section: Future Perspectivesmentioning
confidence: 96%
“…Oral alendronate treatment protected the dogs from osteoclast mediated bone loss and thus implant loosening (Shanbhag et al, 1997). Further experimental studies have confirmed these finding of inhibited particle induced bone resorption in bisphosphonates treated animals (Millett et al, 2002, von Knoch et al, 2005b, Wedemeyer et al, 2005. However, in all studies wear particles were introduced intraoperatively and treatment with bisphosphonates was initiated directly after surgery.…”
Section: Study III (Bisphosphonate Study)mentioning
confidence: 96%
“…This particle induced periprosthetic osteolysis was inhibited by bisphosphonates in experimental studies in dogs (Shanbhag et al, 1997, Millett et al, 2002, von Knoch et al, 2005b, Wedemeyer et al, 2005. However, in a clinical setting of patients with demonstrated aseptic loosening who were awaiting revision surgery, six months treatment with bisphosphonates did not alter the need for revision surgery (Lyons et al, 2009).…”
Section: Study Iii: Bisphosphonatesmentioning
confidence: 99%